Spots Global Cancer Trial Database for bone marrow transplantation
Every month we try and update this database with for bone marrow transplantation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia | NCT00487448 | Myelodysplastic... Acute Myeloblas... | Fludarabine Cytarabine G-CSF Idarubicin Peripheral bloo... Bone marrow tra... | - 75 Years | PETHEMA Foundation | |
| Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children | NCT00695370 | Solid Malignanc... | Pegfilgrastim (... | - 18 Years | University Hospital, Clermont-Ferrand | |
| Bone Marrow Transplantation in Treating Patients With Lymphoma | NCT00002829 | Lymphoma | Recombinant Int... Cyclophosphamid... Etoposide Mesna Bone Marrow Tra... Radiation Thera... | 15 Years - 60 Years | M.D. Anderson Cancer Center | |
| Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation | NCT04727827 | Hematopoietic C... Oncology | Pharmacogenomic... | 18 Years - | Wake Forest University Health Sciences | |
| Exercise Post Bone Marrow Transplant | NCT02320942 | Leukemia | Exercise Interv... | 18 Years - | University of British Columbia | |
| Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab | NCT00946023 | Lymphoma B-cell Lymphoma Non Hodgkin Lym... Chronic Lymphoc... | Fludarabine Cyclophosphamid... Total body irra... Tacrolimus Mycophenolate M... Rituximab Allogeneic Bone... | 1 Year - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab | NCT00946023 | Lymphoma B-cell Lymphoma Non Hodgkin Lym... Chronic Lymphoc... | Fludarabine Cyclophosphamid... Total body irra... Tacrolimus Mycophenolate M... Rituximab Allogeneic Bone... | 1 Year - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Massage for Pediatric Oncology | NCT00843180 | Bone Marrow Tra... Distress | massage | 5 Years - 18 Years | University of California, San Francisco | |
| Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5) | NCT00751894 | Solid Malignanc... | Pegfilgrastim (... | - 18 Years | University Hospital, Clermont-Ferrand | |
| Stem Cell Transplantation for Patients With Hematologic Malignancies | NCT00152139 | Acute Lymphobla... Acute Myelocyti... Chronic Myeloid... Juvenile Myelom... Myelodysplastic... Hemoglobinuria,... Non-Hodgkin Lym... | Allogeneic Stem... Chemotherapy an... | 2 Years - 21 Years | St. Jude Children's Research Hospital | |
| National Longitudinal Cohort of Hematological Diseases | NCT04645199 | Multiple Myelom... Myeloma, Multip... Myelomas, Multi... Acute Myeloid L... Leukemias, Acut... Myeloid Leukemi... Hemophilia Hemophilia A Hemophilia As Hemophilia B Hemophilia Bs Myelodysplastic... MDS Lymphoma Leukemia Aplastic Anemia Bleeding Disord... Bone Marrow Tra... Blood Disease I... | - | Institute of Hematology & Blood Diseases Hospital, China | ||
| Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer | NCT02995330 | Prostate Cancer | Bone marrow tra... Cytoxan testosterone cy... | 18 Years - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients | NCT01015261 | Acute Lymphobla... | Bone Marrow Tra... Chemotherapy | 16 Years - 50 Years | Tehran University of Medical Sciences | |
| Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R | NCT00534469 | Leukemia | aldesleukin filgrastim busulfan cytarabine etoposide idarubicin autologous hema... bone marrow tra... peripheral bloo... total-body irra... | 16 Years - 60 Years | City of Hope Medical Center | |
| Stem Cell Transplantation for Patients With Hematologic Malignancies | NCT00152139 | Acute Lymphobla... Acute Myelocyti... Chronic Myeloid... Juvenile Myelom... Myelodysplastic... Hemoglobinuria,... Non-Hodgkin Lym... | Allogeneic Stem... Chemotherapy an... | 2 Years - 21 Years | St. Jude Children's Research Hospital | |
| IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT | NCT03696537 | Acute Myeloid L... Chronic Myeloid... Acute Lymphocyt... Myelodysplastic... | Fludarabine Total Marrow Ir... | 18 Years - 65 Years | Indiana University | |
| 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome | NCT03670966 | Acute Lymphobla... Acute Myeloid L... Acute Myeloid L... Chronic Myelomo... Myelodysplastic... Recurrent Acute... Recurrent Acute... Refractory Acut... Refractory Acut... Recurrent Mixed... Refractory Mixe... Hematopoietic a... | Astatine At 211... Cyclophosphamid... Total-Body Irra... Peripheral Bloo... Bone Marrow Tra... Mycophenolate M... Recombinant Gra... Fludarabine Pho... Tacrolimus Bone Marrow Asp... Biospecimen Col... | 18 Years - 75 Years | Fred Hutchinson Cancer Center | |
| Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation | NCT00452205 | Gastrointestina... | 20 Years - 70 Years | Komagome Hospital | ||
| Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | NCT00002844 | Leukemia | Cyclophosphamid... Allogeneic Bone... Autologous Bone... Total Body Irra... | 16 Years - 65 Years | M.D. Anderson Cancer Center | |
| Bone Marrow Transplantation in Treating Patients With Lymphoma | NCT00002829 | Lymphoma | Recombinant Int... Cyclophosphamid... Etoposide Mesna Bone Marrow Tra... Radiation Thera... | 15 Years - 60 Years | M.D. Anderson Cancer Center | |
| Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants | NCT00001830 | Chronic Lymphoc... Graft vs Host D... Hodgkin's Disea... Multiple Myelom... Non Hodgkin's L... | Th2 cells in al... Th2 Cells | 12 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children | NCT00695370 | Solid Malignanc... | Pegfilgrastim (... | - 18 Years | University Hospital, Clermont-Ferrand | |
| Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC) | NCT05667766 | Neoplasms Bone Marrow Tra... | Release of Exte... Release of Exte... | - 18 Years | Murdoch Childrens Research Institute | |
| Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury | NCT00031551 | Stomatitis | Etanercept Placebo | 16 Years - | National Institutes of Health Clinical Center (CC) | |
| Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission | NCT02605460 | Acute Myeloid L... Acute Lymphoid ... | Busulfan Cyclophosphamid... CXCR4 Antagonis... Hematopoietic S... | 18 Years - 60 Years | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | |
| Allogeneic Blood Stem Cell Transplantation | NCT00423709 | Hodgkin's Disea... | Allogeneic Bloo... Fludarabine Melphalan | - 65 Years | M.D. Anderson Cancer Center | |
| Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | NCT00002844 | Leukemia | Cyclophosphamid... Allogeneic Bone... Autologous Bone... Total Body Irra... | 16 Years - 65 Years | M.D. Anderson Cancer Center | |
| Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation | NCT02828878 | Hematological M... | Allogeneic MPBC... | 18 Years - 70 Years | Cellect Biotechnology | |
| Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R | NCT00534469 | Leukemia | aldesleukin filgrastim busulfan cytarabine etoposide idarubicin autologous hema... bone marrow tra... peripheral bloo... total-body irra... | 16 Years - 60 Years | City of Hope Medical Center | |
| A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation | NCT00275262 | Hodgkin Disease Lymphoma, Non-H... Multiple Myelom... Mantle Cell Lym... | Leuprolide acet... Matched placebo | 18 Years - 65 Years | Abbott | |
| Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma | NCT00506129 | Lymphoma Disorder Relate... | Fludarabine Melphalan Allogeneic Tran... Thymoglobulin | - 70 Years | M.D. Anderson Cancer Center | |
| Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma | NCT00506129 | Lymphoma Disorder Relate... | Fludarabine Melphalan Allogeneic Tran... Thymoglobulin | - 70 Years | M.D. Anderson Cancer Center | |
| Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma | NCT00506129 | Lymphoma Disorder Relate... | Fludarabine Melphalan Allogeneic Tran... Thymoglobulin | - 70 Years | M.D. Anderson Cancer Center | |
| Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia | NCT01904136 | Accelerated Pha... Acute Myeloid L... Acute Myeloid L... Blast Phase Chr... de Novo Myelody... Myelodysplastic... Recurrent Acute... Recurrent Chron... Therapy-Related... | Allogeneic Hema... Bone Marrow Tra... Cyclophosphamid... Fludarabine Laboratory Biom... Melphalan Mycophenolate M... Natural Killer ... Peripheral Bloo... Tacrolimus Total-Body Irra... | 2 Years - 65 Years | M.D. Anderson Cancer Center | |
| King's Invasive Aspergillosis Study II | NCT02875743 | Aplastic Anemia Leukemia, Myelo... Myelodysplastic... Bone Marrow Tra... | Posaconazole | 18 Years - | King's College Hospital NHS Trust | |
| Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers | NCT00074490 | Lymphoma Leukemia Myeloproliferat... Multiple Myleom... Myelodysplastic... | Rituximab Fludarabine Etoposide Doxorubicin Vincristine Cyclophosphamid... Peripheral bloo... T cell donor ly... Prednisone Allogeneic hema... Filgrastim T-Rapa cell Don... | 11 Years - 90 Years | National Institutes of Health Clinical Center (CC) | |
| The Oronasal Microbiota in Pediatric Oncology Patients | NCT02949427 | Acute Myeloid L... Hematologic Mal... Bone Marrow Tra... | 4 Years - 21 Years | St. Jude Children's Research Hospital | ||
| A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant | NCT00002284 | Lymphoma, Non-H... HIV Infections | Zidovudine | 12 Years - 50 Years | NIH AIDS Clinical Trials Information Service | |
| Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome | NCT01433965 | Acute Myeloid L... Myelodysplastic... | Lenalidomide | 18 Years - 65 Years | University of California, Davis | |
| Blood and Marrow Transplant Clinical Research Network | NCT00023530 | Bone Marrow Tra... Blood Disease Hematopoietic S... Leukemia Multiple Myelom... Myelodysplastic... Graft vs Host D... | fluconazole voriconazole bone marrow tra... thalidomide dexamethasone | 2 Years - | National Heart, Lung, and Blood Institute (NHLBI) | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | NCT00003146 | Multiple Myelom... | busulfan melphalan thiotepa bone marrow tra... peripheral bloo... | - 70 Years | Fred Hutchinson Cancer Center | |
| Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates | NCT00048256 | Adaptation, Psy... Bone Marrow Tra... | - | National Institutes of Health Clinical Center (CC) | ||
| Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome | NCT01433965 | Acute Myeloid L... Myelodysplastic... | Lenalidomide | 18 Years - 65 Years | University of California, Davis | |
| Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer | NCT02995330 | Prostate Cancer | Bone marrow tra... Cytoxan testosterone cy... | 18 Years - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients | NCT03030248 | Clostridium Dif... Hematologic Dis... Bone Marrow Tra... Oncologic Disor... | Vancomycin Oral... Placebo Oral Ca... | 18 Years - | Medical College of Wisconsin | |
| Laser Therapy Prevents Mucositis Oral in Chemotherapy for Bone Marrow Transplantation? | NCT02020928 | Oral Mucositis Effects of Chem... Malignant Neopl... | Low level laser... | 18 Years - 60 Years | Instituto Materno Infantil Prof. Fernando Figueira | |
| Massage for Pediatric Oncology | NCT00843180 | Bone Marrow Tra... Distress | massage | 5 Years - 18 Years | University of California, San Francisco | |
| Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation | NCT00363467 | Acute Myeloid L... | G-CSF Leukapheresis Busulfan Stem cell reinf... | 56 Years - 74 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients | NCT01269203 | Multiple Myelom... | Curcumin Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Blood and Marrow Transplant Clinical Research Network | NCT00023530 | Bone Marrow Tra... Blood Disease Hematopoietic S... Leukemia Multiple Myelom... Myelodysplastic... Graft vs Host D... | fluconazole voriconazole bone marrow tra... thalidomide dexamethasone | 2 Years - | National Heart, Lung, and Blood Institute (NHLBI) | |
| SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia | NCT00487448 | Myelodysplastic... Acute Myeloblas... | Fludarabine Cytarabine G-CSF Idarubicin Peripheral bloo... Bone marrow tra... | - 75 Years | PETHEMA Foundation | |
| Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders | NCT03626285 | Benign Neoplasm Bone Marrow Tra... Hematopoietic C... Malignant Neopl... | Bone Marrow Tra... CliniMACS CD34 ... Peripheral Bloo... | - 70 Years | OHSU Knight Cancer Institute | |
| Exercise Post Bone Marrow Transplant | NCT02320942 | Leukemia | Exercise Interv... | 18 Years - | University of British Columbia | |
| Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis | NCT01749111 | Acute Myelogeno... Acute Lymphoid ... Myeloproliferat... Myelodysplastic... Chronic Myeloid... Chronic Myelomo... | ARM A Cyclophos... ARM B Calcineur... | 18 Years - 60 Years | Hospital Israelita Albert Einstein | |
| Bone Marrow Transplantation in Treating Patients With Lymphoma | NCT00002829 | Lymphoma | Recombinant Int... Cyclophosphamid... Etoposide Mesna Bone Marrow Tra... Radiation Thera... | 15 Years - 60 Years | M.D. Anderson Cancer Center | |
| Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy | NCT01016548 | Lymphoma Multiple Myelom... Influenza A Vir... | AS03-adjuvanted... | 20 Years - 65 Years | University Health Network, Toronto | |
| A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation | NCT00275262 | Hodgkin Disease Lymphoma, Non-H... Multiple Myelom... Mantle Cell Lym... | Leuprolide acet... Matched placebo | 18 Years - 65 Years | Abbott | |
| Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease | NCT04039100 | Multiple Myelom... Lymphoma Bone Marrow Tra... Neoplasms Hematologic Dis... Leukemia, Myelo... | Family Caregive... | 18 Years - | Rigshospitalet, Denmark | |
| Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients | NCT00824993 | Hematological M... | Ibandronate Vitamin Supplem... | 18 Years - | M.D. Anderson Cancer Center | |
| Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants | NCT00001830 | Chronic Lymphoc... Graft vs Host D... Hodgkin's Disea... Multiple Myelom... Non Hodgkin's L... | Th2 cells in al... Th2 Cells | 12 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation | NCT01020175 | Acute Leukemia Chronic Myeloge... Myelodysplastic... | Bone marrow tra... Peripheral bloo... | 18 Years - 55 Years | European Society for Blood and Marrow Transplantation | |
| Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts | NCT00026858 | Neoplasm | collaboration | - | National Institutes of Health Clinical Center (CC) | |
| Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers | NCT02682953 | Bone Marrow Tra... Hematopoietic S... Multiple Myelom... Lymphoma | Neupogen Hyperbaric oxyg... Plerixafor | 21 Years - | University of Maryland, Baltimore | |
| King's Invasive Aspergillosis Study II | NCT02875743 | Aplastic Anemia Leukemia, Myelo... Myelodysplastic... Bone Marrow Tra... | Posaconazole | 18 Years - | King's College Hospital NHS Trust | |
| Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease | NCT02158052 | Multiple Myelom... Amyloidosis | Tacrolimus Equine Anti-thy... Kidney transpla... Bone marrow tra... Total body irra... | 18 Years - 65 Years | Massachusetts General Hospital | |
| Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation | NCT01020175 | Acute Leukemia Chronic Myeloge... Myelodysplastic... | Bone marrow tra... Peripheral bloo... | 18 Years - 55 Years | European Society for Blood and Marrow Transplantation | |
| Mindfulness Meditation in Bone Marrow Transplantation | NCT00165282 | Hematologic Mal... Bone Marrow Tra... Stem Cell Trans... | Mindfulness tra... Nurse education | 21 Years - | Emory University | |
| Laser Therapy Prevents Mucositis Oral in Chemotherapy for Bone Marrow Transplantation? | NCT02020928 | Oral Mucositis Effects of Chem... Malignant Neopl... | Low level laser... | 18 Years - 60 Years | Instituto Materno Infantil Prof. Fernando Figueira | |
| Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | NCT00630565 | Leukemia | sargramostim busulfan cyclophosphamid... dexamethasone etoposide bone marrow tra... hematopoietic s... peripheral bloo... total-body irra... | - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts | NCT00026858 | Neoplasm | collaboration | - | National Institutes of Health Clinical Center (CC) | |
| Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients | NCT01269203 | Multiple Myelom... | Curcumin Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Yoga for Fatigue in the Survivors of Bone Marrow Transplantation | NCT03299465 | Fatigue Cancer | Yoga | 18 Years - | University of Michigan | |
| Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia | NCT01904136 | Accelerated Pha... Acute Myeloid L... Acute Myeloid L... Blast Phase Chr... de Novo Myelody... Myelodysplastic... Recurrent Acute... Recurrent Chron... Therapy-Related... | Allogeneic Hema... Bone Marrow Tra... Cyclophosphamid... Fludarabine Laboratory Biom... Melphalan Mycophenolate M... Natural Killer ... Peripheral Bloo... Tacrolimus Total-Body Irra... | 2 Years - 65 Years | M.D. Anderson Cancer Center | |
| Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation | NCT00363467 | Acute Myeloid L... | G-CSF Leukapheresis Busulfan Stem cell reinf... | 56 Years - 74 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat | NCT02409134 | Quality of Life Graft-vs-Host D... | 18 Years - 75 Years | University of Michigan Rogel Cancer Center | ||
| New York Blood Center National Cord Blood Program | NCT00212407 | Leukemia Lymphoma Genetic Disease Severe Aplastic... Myelodysplasia | Umbilical Cord ... | - | New York Blood Center | |
| Effects of Exercise on Allogeneic Stem Cell Transplant | NCT02900768 | Hematological M... | Exercise | 18 Years - | University of British Columbia |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
